DF/HCC Calendar
Dana-Farber/Harvard Cancer Center – Cancer Disparities Program in Development presents:
Women and Minority Enrollment Targets in Clinical Trials: A Symposium and Panel Discussion on Diversity in Medical Research
Thursday, April 24, 2008
8:00am-12:00pm
Jimmy Fund Auditorium
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA 02115
Continental Breakfast 8:00-8:30am
Keynote Speaker 8:30-9:30am
Steven Epstein, PhD
Author of Inclusion: The Politics of Difference in Medical Research
Panel Discussion 9:30 am – 12:00 pm
David Williams, PhD, MPH, Harvard School of Public Health
Steven Joffe, MD, MPH, Harvard Medical School
Jerry Avorn, MD, Brigham and Women’s Hospital
Lee Nadler, MD, Dana-Farber Cancer Institute
Milagro Grullón, MA, Mayor's Health Task Force, City of Lawrence
Worta McCaskill-Stevens, PhD, National Institutes of Health
Free and open to the public.
Pre-registration required: Email elizabeth_zdunich@dfci.harvard.edu or go to
http://www.dfhcc.harvard.edu/research-programs/discipline-based-programs/cancer-disparities/event-registration/
*About Inclusion: The Politics of Difference in Medical Research by Steven Epstein:
As a society, we have learned to value diversity. But can some strategies to achieve diversity mask deeper problems, ones that might require a different approach and different solutions? With Inclusion, Steven Epstein argues that in the field of medical research, the answer is an emphatic yes.Formal concern with diversity in American medical research, Epstein shows, is a fairly recent phenomenon. Until the mid-1980s, few paid close attention to who was included in research subject pools. Not uncommonly, scientists studied groups of mostly white, middle-aged men—and assumed that conclusions drawn from studying them would apply to the rest of the population. But struggles involving advocacy groups, experts, and Congress led to reforms that forced researchers and pharmaceutical companies to diversify the population from which they drew for clinical research. That change has gone hand in hand with bold assertions that group differences in society are encoded in our biology—for example, that there are important biological differences in the ways that people of different races and sexes respond to drugs and other treatments.While the prominence of these inclusive practices has offered hope to traditionally underserved groups, Epstein argues forcefully that it has drawn attention away from the tremendous inequalities in health that are rooted not in biology but in society. There is, for instance, a direct relationship between social class and health status—and Epstein believes that a focus on bodily differences can obscure the importance of this factor. Only when connected to a broad-based effort to address health disparities, Epstein explains, can a medical policy of inclusion achieve its intended effects. A fascinating history, powerful analysis, and call to action, Inclusion will be essential reading for medical professionals, policymakers, and any concerned citizen.Initiated in 1987, the Biennial Symposium series provides the stage on which we shine a spotlight on the issue of disproportionate cancer incidence, morbidity and mortality in minority and medically underserved populations in the United States and its associated territories. The Symposium brings together those who represent all aspects and perspectives of the disease in collaboration with the leadership and front-line personnel from the affected communities. Our purpose is to engage in a dialogue that explores issues, finds solutions, and makes recommendations for the various complex problems related to cancer.
At the Symposium, decision makers hear, first-hand, from those directly affected by the problem and the policies that surround cancer. Participants from the communities sit at the discussion table to share the most current research, prevention, and treatment strategies. This unique opportunity creates a dynamic synergy in a setting that respects and celebrates our ethnic and cultural diversity, while recognizing our common humanity and the goal of survivorship. That is what keeps us focused on our mutual enemy - cancer.
For more information:
http://iccnetwork.org/symposium/
11th Biennial Symposium
Baylor College of Medicine
1709 Dryden, Suite 1025
Houston, TX 77030
Tel: 713.798.5383 or toll-free 1.877.BIENNIAL (1.877.243.6642)
Fax: 713.798.6222
E-mail: icc-symposium@bcm.edu
Harvard Medical School's successful annual CME course entitled: “ECGs in Clinical Practice: Pearls and Pitfalls," will be held May 3-4, 2008 at the Fairmont Copley Boston. This unique 1.5-day intensive course provides a practical review of ECG interpretation for front-line clinicians in office and acute care settings. Emphasis will be in the detection of potentially life-threatening problems and everyday challenges (e.g., What to do about newly discovered atrial fibrillation?).
This CME/CEU approved program proved to be of major interest to a wide range of attendees including primary care and family physicians, hospitalists, internists, cardiologists, critical care and emergency medicine physicians, anesthesiologists, nurses and technicians.
Course Objectives/Goals include:
Understand basis of ECG analysis and how to accurately diagnose major life-threatening conditions, including P-QRS-T-U abnormalities and arrhythmias/conduction disturbances
Recognize pacemaker patterns and pacemaker malfunction
Know how to avoid major ECG pitfalls and errors
Understand management implications of ECG findings, including cardiac arrhythmias/implantable cardioverter defibrillators (ICDs), and myocardial ischemia/infarction syndromes
Topics are organized around practical “clinical focus” issues, clinical priorities and "can't miss diagnoses."
Trainees (housestaff, fellows and others) will attend for a reduced fee. As a unique feature, registrants will be able to suggest topics and pose questions for discussion in advance of the course.
Please visit our course page at http://www.cme.hms.harvard.edu/courses/ecgs <http://cts.vresp.com/c/?HarvardMedicalSchool/d8565af9b4/267842e4a2/350a74458f> for additional details, course descriptions, program schedule, and registration information.
Call us with any questions or comments at
(617) 667-4267.
We hope to see you in May!
With all best wishes,
Ary L. Goldberger, MD
Peter J. Zimetbaum, MD
Mark E. Josephson, MD
Course Directors
On Friday, April 4, DF/HCC will sponsor an Ovarian Cancer Researchers' Symposium
The Symposium will be held at the Harvard Club (Commonwealth Ave.) in Boston. We will begin at 8AM with breakfast, will serve lunch, and conclude by 3:30pm. Advance registration will be required.
Ursula Matulonis, MD and Planning Committee: Ross Berkowitz, MD, Steve Cannistra, MD, Dan Cramer, MD, Dirk Iglehart, MD, and Carolyn Krasner, MD
The list of abstracts to be presented at the symposium is attached
The agenda for the day is attached
Join us during our monthly Kidney Cancer Program/SPORE meeting for presentations by:
Wayne Marasco, M.D., Ph.D. (DFCI), “PET Evaluation of RCC Metastases using High-Affinity Human Anti-CAIX Monoclonal Antibodies with Optimized Pharmacokinetic Properties”
David Frank, M.D., Ph.D. (DFCI) "Targeting STAT3 for the Molecular Therapy of Renal Cell Cancer."
A National Conference Featuring Keynote Speakers:
Dr. Joycelyn Elders, Former Surgeon General
Miriam Yeung, National Asian Pacific American Women's Forum
Byllye Avery, Avery Institute for Social Change and Black Women's Health Imperative
Join us and more than 300 other activists, mothers, daughters, sisters, caretakers, consumers and community leaders for this national conference to learn and strategize about how we can get quality, affordable health care for all. Together we will discuss and plan for health care reform that will meet the needs of women and families.
This conference will launch a network of trained and outspoken women who are mobilized to work for a health care system that:
· Includes comprehensive reproductive health services
· Meets the needs of diverse women and our families
· Bridges the inexcusable gaps in services and care that we face in the current system
· Provides quality health care that is affordable and accessible for women and our families across the life-span.
Thursday & Friday, April 17 and 18, 2008
Simmons College
Boston, Massachusetts
Raising Women's Voices for the Health Care We Need is a joint project of
The Avery Institute for Social Change
National Women's Health Network
MergerWatch Project
Go to www.raisingwomensvoices.net for more information on the conference.
Register now for early bird registration rates! http://www.raisingwomensvoices.net/RWV-Register-HrUsNw-2008.html
Questions? Give us a call! 866-210-3114
The New England Science Symposium is an opportunity for biomedical and health-related researchers to present their work, exchange ideas, and expand their professional network. African-American, Hispanic, and American Indian/Alaska Native individuals are particularly encouraged to participate.
Researchers from all levels of higher education are welcome: postdoctoral fellows; medical, dental, and graduate students; post-baccalaureates; and college and community college students.
There is no registration fee, but pre-registration is required.
Please visit the website for more information: http://www.mfdp.med.harvard.edu/med_grad/ness/
The Boston Park Plaza Hotel
Friday evening, April 4 and Saturday, April 5, 2008
On behalf of the Biomedical Science Careers Program (BSCP), we wish to invite you to join us for the ninth biennial New England-wide BIOMEDICAL SCIENCE CAREERS STUDENT CONFERENCE for postdoctoral fellows; medical, dental and graduate students; post-baccalaureates; college and community college students; and high school seniors and juniors.
The conference will take place at The Boston Park Plaza Hotel in Boston, Massachusetts on Saturday, April 5, 2008 from 7:30 AM to 6:00 PM. All postdoctoral fellows, medical, dental, graduate and out-of-town post-baccalaureates, college and community college students are also welcome to join us (pre-registration required) on Friday evening, April 4, for dinner and keynote address. Dinner will be followed by interactive workshops.
A tentative agenda is attached here.
There is no registration fee for the conference but pre-registration is required. If you want to receive application form, tentative agenda and further information, please email us your current postal mailing address as soon as possible.
Fahri Ercem
Program Coordinator
Biomedical Science Careers Program
c/o Harvard Medical School
164 Longwood Avenue, 2nd Floor
Boston, MA 02115-5818
Phone: 617-432-2729
Fax: 617-432-3834
Email: fahri_ercem@hms.harvard.edu
www.bscp.org
Dana-Farber/Harvard Cancer Center
Cancer Disparities Program-in-Development
In Cooperation with
HMS Office of Diversity and Community Partnership
Fourth Annual Junior Investigators’ Health Disparities Research Poster Session
Thursday, May 1, 2008
Joseph B. Martin Conference Center
Harvard Medical School
9:00am -12:00pm
- Graduate Students, Fellows, or Junior Faculty welcome
- Broad range of topics welcome related to understanding and eliminating health disparities and inequities (e.g. race, ethnicity, socioeconomic position, language, literacy, gender, sexuality, disability, immigrant status, age, insurance status, housing status, geographic location)
- Special interest in Cancer Disparities and/or Clinical and Translational Health Disparities Research
- Poster Session to coincide with 2008 Minority Health Policy Annual Meeting
- Opportunity to network with other researchers and grant-makers
- DEADLINE EXTENDED: Submit Abstract Registration Form by April 11, 2008 (see attached file)
- Questions? Please email kdonelan@partners.org or call Karen Donelan, ScD at Mass General Hospital Cancer Center: 617 726 0681
*Posters already prepared for other meetings are welcome*
Please join us for a special lecture in our weekly outcomes research seminar series:
The science and epidemiology of US cancer disparities: Race/ethnicity, class, and gender
by Nancy Krieger, PhD
Professor of Society, Human Development, and Health
Harvard School of Public Health
Saturday, May 3, 2008 · 9:00 am - 4:00 pm
Sheraton Framingham Hotel
1657 Worcester Road, Framingham, MA
Keynote Speakers:
· Joyce Kulhawik, WBZ-TV, four-time cancer survivor
· Harold P. Freeman, M.D., President and Founder of the Ralph Lauren Center for Cancer Care and Prevention, the pioneer of cancer patient navigation
Plus empowering, action-oriented, breakout sessions on issues of treatment and quality of life
Who Should Attend:
· Newly diagnosed individuals
· Those living with cancer
· New and long-term survivors
· Caregivers and family members
· Health care professionals
· Public policy makers
Registration fee: $20/person
Make checks payable to: New England Coalition for Cancer Survivorship
Mail to: Green Associates 200 Lincoln St., #201 Boston, MA 02111
If you are deaf or hard of hearing, or are a person with a disability who requires accommodation, please contact Green Associates at the phone or email above or call 617-624-5992 (TTY) by April 18, 2008.
For more Information:
Phone: 617-482-3044
Email: cancersummit@green-associates.com
Scholarships available.
Charles Balch, M.D.
Professor of Surgery and Oncology
Johns Hopkins Medical Institutions
Baltimore, Maryland
“Melanoma as an example of evidence-based medicine"
Light refreshments will be served prior to Dr. Balch’s lecture starting at 8:30am.
Also a Partners or Harvard ID is necessary for entrance into the Simches Conference Center, if you need access please contact Brie Trefrey , Btrefrey@partners.org
REQUEST FOR APPLICATIONS
Genentech, Inc. Kidney Cancer Career Development Award-Dana Farber/Harvard Cancer Center Kidney Cancer Program
DUE DATE: 04/18/08
The Kidney Cancer Program of the Dana Farber/Harvard Cancer Center, under the leadership of Dr. Michael B. Atkins, seeks applications for the Genentech, Inc. Career Development Award in Kidney Cancer Research. Funding has been provided by Genentech, Inc. to be awarded to through the Kidney Cancer Program of DF/HCC. Eligible candidates are those who are in their final year of clinical fellowship or postdoctoral fellowship (MD, PhD or MD/PhD required) or within their first 3 years on staff. A prior track record in kidney cancer research is preferred but not required. The awardee will receive up to two years of funding at up to $60,000 per year (inclusive of indirect costs), which can be used for salary and/or support of research at Harvard Medical School, the Harvard School of Public Health or any of the Harvard-affiliated hospitals. Proposals should present a two year research plan with clearly defined milestones. Applicants will be evaluated using the 5 point NIH scale according to the following criteria-
1. The scientific merit/quality of the proposal (coherent presentation, candidate's own work, kidney cancer focus, translational nature)
2. The quality of the candidate (quality of previous work; potential for academic career in kidney cancer)
3. The quality of the research environment (mentor support and track record, resources available)
Consideration will also be given to investigators expressing interest in shifting their research focus to kidney cancer. In this instance, items that will also be considered include:
1. The seriousness of the commitment to translational research in kidney cancer
2. The willingness of the individual to continue a productive relationship with the SPORE and the Kidney Cancer Program
The awardee will be expected to become a member of the DF/HCC Kidney Cancer Program and participate in Program activities including monthly research conferences, thrice yearly half-day seminars, and the annual retreat. Women and minority candidates are encouraged to apply. Applications should be sent electronically to the Program Administrator, Aline D. Nandelstadt at anandels@bidmc.harvard.edu no later than 3 pm on 04/18/08. Minority and women applicants are strongly encouraged to apply.
Applications must contain the following components:
- Abstract of proposed research
- Abbreviated Research Plan including the Specific Aims, Background and Significance, Preliminary Data, and Experimental Methods, not to exceed 5 pages, exclusive of the proposed milestones and literature cited.
- Applicants Career Goals (1 page)
- Research and Environment for proposed research
- Mentor(s) Letter of Support
- Applicant’s NIH Biosketch
- Mentor’s Biosketch
- Applicant’s NIH Other Support Page
- Proposed Budget; must not exceed $60,000/year (Inclusive of indirect costs) x 2 years
- Cover letter with institutional signature
- IRB approval documents (if applicable)
- Human Subject Training Certificate (if applicable)
Please note that support for this grant has been made available through Genentech, Inc.
Anticipated Award Dates: 06/01/08 – 05/31/10
VA Outcomes Group
Department of Veterans’ Affairs
White River Junction, VT
The April 17th meeting of the LAM/TSC Seminar Series will feature Bill Sellers, MD of Novartis Institutes for BioMedical Research. Dr. Sellers has significant experience and an international reputation in both clinical and basic research, with a focus on the basic mechanisms of tumor suppressor genes in prostate cancer. He has made many important contributions to the discovery of molecular pathways of cancer and the understanding of cancer genetics. Our discussant has experience in the clinic using the drugs (developed by Novartis and others) that are now being tested in LAM/TSC and various cancers. Dr. Kulke will lead a provocative conversation about the talk’s implications for treatment and then we will break for dinner and informal networking
CME Credit is available. Please RSVP
This annual event highlights the achievements and focuses on the development of new strategies for the treatment of cancer patients
David R. Parkinson, M.D.
President and CEO,
Nodality, Inc.
“The Evolution of Cancer Therapeutics”
Wednesday, April 9th, 2008, 4:00pm
Dana-Farber Cancer Institute
1 Jimmy Fund Way, Smith Building, room 308/309
Boston, MA 02115
With the generous support of family and friends, as well as the Medicinal Chemical Group, the Northeastern section of the American Chemical Society, and the Dana Farber Cancer Institute, a fund was created in 1994 and endowed in 2001. The Andrew H. Weinberg Memorial Endowment Fund is dedicated to bringing researchers together from the field of chemotherapy development with those in the medical community at large, helping to foster an environment for synergy and originality in cancer research.
The success of the Weinberg Symposium is evidenced by the large and enthusiastic turnout for past speakers, which have included such notables as Senator Edward M. Kennedy, Richard Klausner, M.D., Judah Folkman, M.D., and Leroy Hood, M.D., Ph.D.
For more information, please contact Caleb King at 617-632-2072 or caleb_king@dfci.harvard.edu
Is there the Courage to Change the American Diet?
Kelly Brownell, PhD
Professor of Psychology, Epidemiology and Public Health
Director, Rudd Center for Food Policy and Obesity
Yale University
Monday, March 31 @ 12:30pm in Kresge G1
Cancer Prevention Dialogues are co-hosted by the Dana Farber/Harvard Cancer Center.
A Talk by Dr. Alan M. Krensky
NIH Deputy Director for the Office of Portfolio Analysis and Strategic Initiatives
Wednesday, April 2, 2008 at 4:00 P.M.
Broad Institute Audiotorium
7 Cambridge Center
***Dr. Krensky is in charge of the NIH Roadmap for Medical Research; he will also be discussing this program in addition to his scientific presentation***
Dr. Krensky is the first Director of the Office of Portfolio Analysis and Strategic Initiatives (OPASI) and a Deputy Director of the National Institutes of Health. For the past 23 years, he was at Stanford University where he served as the Shelagh Galligan Professor of Pediatrics, Associate Dean for Children's Health, Associate Chair for Research, Chief of the Division of Immunology and Transplantation Biology and Executive Director of the Children's Health Initiative. A medical graduate of the University of Pennsylvania in 1977, he trained in pediatrics and nephrology at Boston Children's Hospital and immunology with Steven Burakoff at the Dana-Farber Cancer Institute. After one year on the faculty at Harvard, he moved to Stanford as Assistant Professor of Pediatrics in 1984. He was appointed Shelagh Galligan Professor in 1995 and has been at NIH since July 8, 2007.
The seminar is open to the public, but due to limited seating, please register by e-mailing cancer@mit.edu with "Krensky seminar" in the Subject line
Harvard Medical School Office for Diversity and Community Partnership is pleased to announce the 2008 ALVIN F. POUSSAINT, MD, VISITING LECTURESHIP
“Racial and Ethnic Disparities: Institutional Responses, Personal Reflections”
This year's lecturer is M. Roy Wilson, MD, MS, the Chancellor of the University of Colorado Denver, and a graduate of the HMS Class of 1980. He performed both his ophthalmology residency and glaucoma fellowship at the Massachusetts Eye and Ear Infirmary. Dr. Wilson is an ophthalmologist whose scientific contributions have bridged the fields of ophthalmology and epidemiology. He is also a former medical school dean.
RSVP to Althea Roach Thomas at 617-432-0161 or althea_roachthomas@hms.harvard.edu
Monday, March 31, 2008
5:00 - 6:00 pm
The Waterhouse Room
Gordon Hall of Medicine
25 Shattuck Street
Boston, MA 02115
Join Dr. Nancy Krieger and the Public Health Intersections with Politics group for the screening and discussion of...
UNNATURAL CAUSES: Is Inequality Making Us Sick?
A PBS documentary series a exploring racial and socioeconomic inequities in health in the U.S.
****STARRING****
Nancy Krieger, David Williams, Ichiro Kawachi, Jack Shonkoff and Jim Yong Kim!
Premier Screening of UNNATURAL CAUSES at the Harvard School of Public Health
When: Thursday, April 3rd from 8:00-11:00 pm
Where: Room 110 (Dean's room), Kresge and cafeteria
Harvard School of Public Health (677 Huntington)
8:00 - 8:30: Refreshments
8:30 - 9:30: Episode 1: "In Sickness and in Wealth"
9:30 - 10:00: discussion with Dr. Nancy Krieger (& more refreshments)
10:00 - 11:00: Episode 2 (live on TV): "When the Bough Breaks" & "Becoming American"
Through this screening, organizers and attendees will hope to spark discussion to increase public awareness of the alarming socio-economic and racial disparities in health and their human and financial costs as well as inject considerations of social and economic policy into future discussions on health.
FOR RSVP and questions: ndhavan@hsph.harvard.edu
Sponsored by HSPH Public Health Intersections with Politics (PHIP) Student Group and the Center for Society and Health
http://www.pbs.org/unnaturalcauses/
VASCULAR BIOLOGY SEMINAR
THURSDAY, APRIL 10, 2008
SPEAKER: KLAUS M. HAHN, Ph.D.
Thurman Distinguished Professor of Pharmacology
Departments of Pharmacology and Medicinal Chemstry
University of North Carolina, Chapel Hill
North Carolina
TITLE: "NEW TRICKS AND TOOLS TO VISUALIZE ENDOGENOUS SIGNALING NETWORKS - MULTIPLEX BIOSENSOR IMAGING AND GENETICALLY ENCODED CAGED PROTEINS"
4:30 PM
ENDERS AUDITORIUM
REFRESHMENTS AVAILABLE @ 4:15 PM
What’s The Use Of Race?
Race continues to thrive as a category of analysis among state and federal institutions and in medical, scientific and social research. Despite concerns that race is a hollow and misleading concept, studies of race have produced overwhelming documentation of inequalities from birth to education, income, crime, punishment, disease, treatment and death. Can race and ethnicity be objects of analysis and targets of policy, to alleviate inequalities, without causing harm by reifying invidious distinctions?
This conference probes these quandaries by bringing together researchers and journal editors in medicine, science, law, and social science to explore the competing interests that make studies of race both feared and desired.
The conference is free and open to the public.
Website for more info including abstracts: http://web.mit.edu/csd/WUR/Welcome.html
NOTE: Pre-registration is requested. Email your name and affiliation to Ian Whitmarsh whitmars@mit.edu
25-26 April 2008
MIT Faculty Club, 6th floor
50 Memorial Drive,
Cambridge MA
Sponsored by the MIT Center for the Study of Diversity in Science, Technology, and Medicine and the MIT Program in Science, Tehcnology and Society, with support from the Andrew W. Mellon Foundation.
presented by
Alan M. Krensky, M.D.
NIH Deputy Director for the Office of Portfolio Analysis and Strategic Initiatives (OPASI)*
Wednesday, April 2
4:00 p.m.-5:00 p.m.
Broad Institute Auditorium, 7 Cambridge Center, Cambridge, MA 02142
Dr. Krensky will discuss the
1) the Office of Portfolio Analysis and Strategic Initiatives at NIH;
2) Networks, Clinical and Translational Science and Immune Tolerance; and
3) Dichotomies, Biology/Medicine, Discovery/Cure, and Evidence-based/Personalized Medicine. These activities and concepts are transforming the way we do biomedical science and may
impact American competitiveness in a "flat" world.
The seminar is open to the public, but due to limited seating, please register by e-mailing lubien@mit.edu with "Krensky seminar" in the Subject line
Join us for breakfast and a poster session from 9 to 10 a.m. followed by “State of Breast Cancer Research and Cancer Policy” panel discussion and luncheon with keynote speaker, Eric Winer M.D., Susan G. Komen for the Cure Chief Medical Advisor and Director of Breast Oncology Center, Dana-Farber Cancer Institute.
RSVPs are required. Please email kcc@komenmass.org or call 781-341-3800.
For parking and public transportation information log onto www.theconfcenter.hms.harvard.edu/parking
Breast Cancer: Closing the Research Gap
A Susan G. Komen for the Cure Symposium
Thursday, April 10, 2008
Joseph B. Martin Conference Center
Harvard Medical School, Boston
9:00 a.m. to 1:00 p.m.
Program
Moderator – Brian Gibbs, PhD, Director of the Program to Eliminate Health Disparities, Department of Health Policies and Management at the Harvard School of Public Health
Introduction – Miriam May, Executive Director, Massachusetts Affiliate, Susan G. Komen for the Cure
- State of Breast Cancer and Cancer Policy – Diane Balma, Vice President of Public Policy, Susan G. Komen for the Cure
- Breast Cancer Research – Finding and Delivering the Cures
A. Risk and Prevention – Judy Garber M.D. M.P.H., Associate Professor, Department of Pathology, Harvard Medical School and Director, Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute
B. Translational Research and Personalized Therapies – Steven Isakoff M.D. Ph.D., Assistant in Medicine, MGH Cancer Center, Massachusetts General Hospital
C. Pathology and Tissue – Laura Collins M.B.B.S., Associate Professor, Department of Pathology, Harvard Medical School and Associate Director, Division of Anatomic Pathology, Beth Israel Deaconess Medical Center
D. Disparities Research – James Michaelson Ph.D., Department of Pathology, Harvard Medical School & Division of Surgical Oncology, Massachusetts General Hospital
E. Komen-funded “Long Term Quality of Life in Black Women Breast Cancer Survivors” – Dr. Margaret Barton-Burke, Assistant Professor, University of Massachusetts, Amherst
- A Survivor’s Story – Erin DeRosa, Breast Cancer Survivor
- What You Can Do:
I Vote for the Cure and Public Policy – Shelley Fuld Nasso, Susan G. Komen for the Cure Advocacy Alliance
Keynote Address – Eric P. Winer, MD, Chief Scientific Advisor, Susan G. Komen for the Cure, and Director Breast Oncology Center, Dana-Farber Cancer Institute
VASCULAR BIOLOGY SEMINAR
THURSDAY, APRIL 17, 2008
SPEAKER: CLIFFORD A. LOWELL, M.D., Ph.D.
Professor and Chairman
Department of Laboratory Medicine
University of California, San Francisco
San Franciso, CA
TITLE: "CONVERGENCE OF IMMUNORECEPTOR AND INTEGRIN SIGNALING PATHWAYS IN LEUKOCYTES"
4:30 PM
ENDERS AUDITORIUM
REFRESHMENTS AVAILABLE AT 4:15 PM
The Division of Hematology/Oncology
at Children’s Hospital Boston presents
Bone Marrow Transplant Seminar Series
Featuring
Naomi Taylor, M.D., Ph.D.
Directeur de Recherche, Institut de Génétique Moléculaire
Group Leader, Immunomodulation and Immunotherapy
Job Talk:
Glut1, glucose and vitamin C; a new look at human lymphopoiesis and erythropoiesis
Monday, April 14, 2008
5:00-6:00 PM
Children’s Hospital Boston
Enders Auditorium
320 Longwood Avenue
Boston, Massachusetts
Please Note Upcoming Job Talks:
Wed. April 23 – Dr. Fabio Candotti
Mon. May 5 – Dr. Michel Sadelain
Mon. May 12 – Dr. Crystal Mackall
Mon. May 19 – Dr. Pavan Reddy
Mon. June 23 - Dr. Laurence Cooper
Mon. July 07 – Dr. Paul Szabolcs
Mon. July 28 – Dr. George Daley
“Mining the Cancer Genome”
Lynda Chin, MD,
Associate Professor
Harvard Medical School,
Dana-Farber Cancer Institute
Boston, MA Tuesday
April 8th 2008, 4:00pm
Host: Myles A. Brown, M.D.
DFCI Tel: 617-632-4750
The Charles I. Siegal Memorial Lecture
“Nuclear Orphan Receptor, COUP-TFII, in Angiogenesis and Vessel Development”
Sophia Y. Tsai, Ph.D.
Professor, Dept. of Molecular and Cellular Biology
Program in Developmental Biology
Baylor College of Medicine,
Houston, TX
Tuesday April 22nd 2008
4:00pm Jimmy Fund Auditorium
Host: Pere Puigserver, Ph.D.
DFCI Tel: 617-582-7977
Trained as a psychologist, Dr. Hesse has spent most of his career working to improve the ways in which mediated communication environments can be utilized to support behaviors in positive ways. His work has taken him into the areas of human-computer interaction, medical informatics, health psychology, media psychology, interpersonal communication, health communication, and artificial intelligence.
On April 11th at 12:30 PM in FXB G13, Dr. Hesse will deliver a lecture entitled “From Gutenberg to Google: Health Communication in a World Gone Flat”.
This presentation is co-sponsored by Health Disparities Program in Development, DF/HCC, Initiative to Eliminate Cancer Disparities, DF/HCC and Risk Reduction Program, DF/HCC.
We hope that you can join us for this exciting lecture.
What: “From Gutenberg to Google: Health Communication in a World Gone Flat”
When: Friday, April 11, 2008 from 12:30-1:30PM
Where: FXB G13 (connected to the Kresge building at 677 Huntington Ave)
LOH without LOH: Monoallelic expression in the human genome
Presented by Alexander Gimelbrant, PhD
Center for Human Genetic Research
Massachusetts General Hospital
Hosted by Peter Sicinski, MD, PhD
Stephen Bunnell, Ph.D.
Tufts/ NE Medical Center
Thursday, April 17th, 2008
3:30 PM
SMITH 308-309
Web Seminar: Creating Equity Reports: A Guide for Hospitals
On April 24th, from 3-4:30PM EST, join The Disparities Solutions Center as we continue our Robert Wood Johnson Foundation sponsored web seminar series.
During the web seminar Dr. Robin Weinick, PhD, lead author of the Guide, will explain its use as a resource that can help staff develop an equity report. Topics covered in the guide include practical information on how to collect data on race, ethnicity, language, and socioeconomic status – and how to use those data to develop an equity report that will allow your hospital to take action. Dr. Weinick will be joined by three representatives from hospitals featured in the report: Baylor Health Care System, Seattle Children's Hospital, and Beth Israel Deaconess Medical Center, and by Dr. Katherine Flaherty, also an author of the Guide.
The 90-minute, interactive, web-based seminar is free and open to the public.
Register now as space is limited. https://rwjf.webex.com/mw0305l/mywebex/default.do?nomenu=true&siteurl=rwjf&service=6&main_url=https%3A%2F%2Frwjf.webex.com%2Fec0600l%2Feventcenter%2Fevent%2FeventAction.do%3FtheAction%3Ddetail%26confViewID%3D195334400%26siteurl%3Drwjf%26%26%26
More information on the Guide can be found on the resources page of the DSC website: http://www.massgeneral.org/disparitiessolutions/resources.html
The Guide will also be available free of charge on this site after the web seminar.
The HMS Office for Diversity and Community Partnership presents The 2008 Leadership and Faculty Development Conference
Success in academic medicine requires today’s clinicians and researchers to be fully prepared as leaders and as scientists. Successful leaders know how to manage their own visibility within an organization, build trust and credibility, advocate effectively for issues of concern, and translate community-based interests and activities into academic scholarship. This Conference will provide HMS junior faculty, clinical fellows, and research fellows with information and skills needed for professional and career advancement in academic medicine, and specifically advancement within the Harvard Medical School Community.
This conference is geared toward junior faculty, clinical fellows, and research fellows.
You can attend the conference for 1 day, 2 days, or all 3 days.
Attached are the brochure (with full agenda) and registration form.
Direct all calls, emails and registrations to: Terésa Carter, 617-432-1892 or teresa_carter@hms.harvard.edu.
Harvard Medical School
Office for Diversity and Community Partnership
2008 Leadership and Faculty Development Conference
Tuesday, April 29, 2008
Wednesday, April 30, 2008
Friday, May 2, 2008
Waterhouse Room, Gordon Hall
Harvard Medical School
25 Shattuck Street, Boston, MA
As part of the DF/HCC Clinical Investigator Education Series, Dr. Jeffrey Clark will present an overview of the preparation and maintenance requirements involved with an investigator-held IND. The speaker will review the considerations in determining whether an IND is needed, the responsibilities and data reporting requirements of the physician IND holder, and the resources available to keep your IND in compliance with FDA regulations.
Dr. Clark is a practicing medical oncologist in the Division of Hematology/Oncology at the Massachusetts General Hospital and the Medical Director for DF/HCC Clinical Trials Operations. Dr. Clark conducts gastrointestinal cancer research and has extensive expertise in Phase I clinical trials.
This program will be video broadcast to the MGH CCPO Conference Room. Category 1 CME credits are available.
Sponsored by the DF/HCC Clinical Trials Education Office (CTEO)
The Department of Cancer Biology and Women's Cancers Program, DFCI, together with the Department of Pathology at HMS present a special seminar:
Kinase Signaling in Breast Cancer: From PI3K to the Kinome
by Jean Zhao, PhD
Dana-Farber Cancer Institute
hosted by Peter Sicinski, MD, PhD
Wednesday, April 23rd, 2008
Harvard School of Public Health
Kresge Room 502
12:30pm-1:30pm
"Molecular and Genetic Predictors of Mammographic Density: Insights into the Pathogenesis of Breast Cancer"
Dr. Rulla Tamimi, ScD
Assistant Professor of Medicine and Epidemiology,
Harvard Medical School and Harvard School of Public Health
Vascular Biology Seminar
Thursday, May 1, 2008
Speaker: Madesh Muniswamy, Ph.D.
Research Assistant Professor (Cancer Biology)
Institute for Environmental Medicine (IFEM)
Department of Cancer Biology
University of Pennsylvania, PA
Philadelphia, PA
"INFLAMMATORY CELL REDOX SIGNALING IN VASCULAR FUNCTION"
4:30 PM
Enders Auditorium
Refreshments available @ 4:15 PM
Please see the attached flier.
For more information, call Betty Yau at 617-636-4363.
FREE oral cancer screening * massage therapy * information & referral services * health information
Asian Cancer Awareness Day
Saturday, April 26, 2008 (9:30 am - 12:30 pm)
Tufts Medical Center
Atrium Lobby & Wolff Auditorium
(800 Washington Street, Boston Chinatown, MA 02111)
Donna Vallone, PhD
Senior Vice President of Research and Evaluation
American Legacy Foundation
WHAT: A conversation with Donna Vallone, PhD
WHEN: Tuesday, April 22, 2008 from 12:30-1:30 PM
WHERE: Kresge G3
We look forward to seeing you at this exciting lecture!
Dr. Vallone oversees Legacy’s portfolio of internal, contract and grant-funded research and evaluation studies. Major areas of research include the ongoing evaluation of the truth® campaign, a youth-oriented tobacco countermarketing campaign, and evaluation of EX, Legacy’s cessation campaign for adult smokers. Dr. Vallone has also been at the forefront of the establishment of the National Institute for Tobacco Research and Policy Studies, which is being created by Legacy in affiliation with Johns Hopkins University School of Public Health. The Institute will advance tobacco control research and policy studies and facilitate the translation of empirical findings into practical public health interventions.
Sponsored by
HEALTH COMMUNICATION CONCENTRATION, HARVARD SCHOOL OF PUBLIC HEALTH
HEALTH COMMUNICATION CORE, DANA-FARBER/HARVARD CANCER CENTER
Co-Sponsored by
HEALTH DISPARITIES PROGRAM IN DEVELOPMENT, DF/HCC
INITIATIVE TO ELIMINATE CANCER DISPARITIES, DF/HCC
RISK REDUCTION PROGRAM, DF/HCC
The Department of Cancer Biology, DFCI, and the Department of Pathology, HMS, present a special seminar:
Activities of a Chromatin-Remodeling Complex during DNA Damage Responses
by Ashby Morrison, PhD
UT MD Anderson Cancer Center
Smithfield, TX
hosted by Bruce Spiegelman, PhD
A special seminar presented by the Department of Pediatric Oncology, DFCI, and the Department of Neurobiology, HMS
The Overarching Importance of cAMP Levels to Brain Tumor Growth
by Joshua Rubin, MD, PhD
Washington University School of Medicine
St. Louis, MO
hosted by Rosalind Segal, MD, PhD
A series of product development presentations sponsored by DF/HCC
PRESENTED BY: GLAXO SMITHKLINE
Presented by:
Peter Ho, MD, PhD Senior Vice President Oncology CEDD
Barbara Weber, MD, Vice President of Discovery and Translational Medicine
TOPICS/PRODUCTS TO BE PRESENTED:
Decision-making process in Drug Development at GSK
GSK Pipeline and Translation Efforts
April 24, 2008, 2008, 4:00 - 5:30 PM
Dana-Farber Cancer Institute, Dana 1620
Video Conference to MGH Lawrence House 2nd floor conference room
These presentations are not for the public and designated for members of the DF/HCC institutions only.
PARKING: Please park in DFCI’s Smith Garage at One Jimmy Fund Way.
DFCI will validate parking for the event.
PROGRAM IN CANCER IMMUNOLOGY SEMINAR SERIES
Thomas S. Kupper, MD
Thomas B. Fitzpatrick Professor of Dermatology (HMS)
Director, Harvard Skin Disease Research Center
Chairman, Department of Dermatology (BWH + DFCI)
Steven Ringer, BWH
Long-term Effects of Prematurity on Kids and Families
Alan Robin
Grand Rounds
Elliot Chaikof, Emory University
The Evolving Impact of Materials Science and Engineering in Vascular Surgery and Endovascular Therapy
Sudhir Kakar, MEEI
Culture in Psychotherapy
Scott Emr, Cornell Institute for Cell and Molecular Biology
Phosphoinositide Lipid Signaling in the Regulation of Membrane Transport and Organelle Identity
Gabriel Hortobagyi, University of Texas
Assessing Prognosis for Early Breast Cancer: Clinical Versus Genomic Profiles
R. William Mason, Faulkner Hospital
ENT for the PCP
Jill Hooley, MCL
The Role of Criticism in Psychiatric Relapse: Depression, Schizophrenia, Families, and the Brain
Roland Baron, HSDM
Integrin Signaling in Osteoclasts and Its Role in Cytoskeletal Organization and Bone Resorption
Mark Ragins, The Village Integrated Service Agency
Recovering from Mental Illness: Temporary Fad or Real Transformation
David Banks, Duke University
Statistical Issues in Metabolomics
JoAnn Manson, BWH
Lessons on Cardiovascular Disease from the Women's Health Initiative
Grace Huang, Richard Schwartzstein, BID
Educational Research: Challenges and Opportunities: Lessons from Millennium Conference
Augustine Choi, BWH
Can Inhaled Carbon Monoxide be a Therapy for Human Disease?
Sergey Shevkoplyas, HU
Networks of Microchannels: Is There Anything They Can't Do?
James Zheng, Robert Wood Johnson Medical School
Cofilin Actin' Up in Growth Cone Guidance and Synapse Development
Infectious Disease Epidemiology Seminar
Bruno Conti, The Scripps Research Institute
Central Regulation of Core Body Temperature and Aging: Lessons From a Transgeneric Model
Aviva Lee-Parritz, BWH
What is New in Managing Gestational Diabetes?
Rachel Miller, Columbia University
Prenatal and Early Postnatal Exposures and Asthma Risk -- How?
Brendan Bohannan, University of Oregon
The Macroecology of Microorganisms
J. Michael Dixon, Western General Hospital, Scotland
Breast Conserving Surgery: Extending Breast Conserving Surgery and Improving Cosmetic Outcome
Merav Socolovsky, University of Massachusetts
Survival Pathways in Erythropoietic Stress
David Lewis, University of Pittsburgh
2008 Mysell Lecture: Dissecting the Disease Process of Schizophrenia: Towards the Development of Pathophysiologically Based Treatments
Norman Daniels, HSPH
Just Health: Meeting Health Needs Fairly
2008 Minority Health Policy Annual Meeting
Thomas Perez, Maryland Department of Labor, Licensing, and Regulation
Ram Chuttani, Douglas Pleskow, BID
Advances and Innovation in GI Endoscopy: A Multimedia Presentation
Beth Beighlie, HMS
Imaging Made Easy Seminar: Poster-making for Large Format Printer
Anthony Bateman, University College of London
Recent Developments in the Treatment of Borderline Personality Disorder
David Lewis, University of Pittsburgh
Adolescence-related Brain Development and Vulnerability to Schizophrenia
Constance Cepko, HMS
Cell Fate Determination in the Vertebrate Retina
Pamela Douglas, Duke University
Shaping the Future of Cardiovascular Imaging
Philipp Scherer, University of Texas Southwestern
BID Endocrine Grand Rounds
Junichi Takagi, Osaka University
Development of a Novel Peptide Affinity Tag System for One-step Purification of Recombinant Proteins
Program in Integrative Developmental Biology
When: Friday, May 2nd 1:30-5pm (note: this is a slight time change)
Where: Harvard Medical School, Cannon Room
Description:
No registration is required to attend on the 2nd.
Lecturers:
John Blenis, Ph.D., Professor of Cell Biology at HMS. Go to http://cellbio.med.harvard.edu/faculty/blenis/index.html to find out more.
Amy Farber, Ph.D., Instructor in Social Medicine at HMS and Executive Director of the LAM Treatment Alliance.
David Kwiatkowski, M.D., Ph.D., AssociateProfessor of Medicine at HMS. See his lab's website at http://www.hms.harvard.edu/dms/bbs/fac/kwiatkowski.html
Brendan Manning, Ph.D., Assistant Professor of Genetics and Complex Diseases at HSPH. For more information go to http://www.hsph.harvard.edu/faculty/brendan-manning/manning-lab/index.html
David Sabatini, M.D., Ph.D., Associate Professor, Department of Biology, MIT. Go to http://web.wi.mit.edu/sabatini/ to find out more.
Check the iDB website for additional details, including recommended readings for this nanocourse at http://idb.med.harvard.edu/content/category/6/107/27/
A special seminar presented by the Department of Cancer Biology and Women's Cancers Program, DFCI and the Department of Pathology, HMS
Seeing Tumors in Context: New Insights into the Tumor Microenvironment in Cancer Progression and Treatment
Presented by Mikala Egeblad, PhD
University of California, San Francisco
Hosted by peter Sicinski, MD, PhD
“How the ER gets into shape”
Tom A. Rapoport, Ph.D.
Professor of Cell Biology,
Harvard Medical School,
HHMI Investigator,
Boston, MA
Tuesday, April 29, 2008
4:00 p.m.
Jimmy Fund Auditorium
Host: Myles A. Brown, M.D.
DFCI Tel: 617-632-4750
Isiah Harris, Evelyn Mok, BWH
OB-GYN Resident Grand Rounds
When: April 28, 2008 - 12:30pm - 1:30pm
Where: Harvard Institutes of Medicine, 10 Floor Conference Room (#1031), 77 Avenue Louis Pasteur, Boston
Description:
Guest Speaker:
Conny Bonifer
Head of Division of Experimental Hematology
University of Leeds
Contact: Toya Dessesaure, 617.667.1351 or tdessesa@bidmc.harvard.edu
Dana-Farber/Harvard Cancer Center
A Comprehensive Cancer CenterDesignated by the National Cancer Institute